Natural Antioxidants and Hypertension: Promise and Challenges

Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Oxidative damage is strongly implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease and stroke (brain ischemia/reperfusion injury). The availability of transgenic and toxin-inducible models of these conditions has facilitated the preclinical evaluation of putative antioxidant agents ran...

Oxidative stress and tardive dyskinesia: role of natural antioxidants

Schizophrenia is a devastating psychiatric disorder that affects 1% of population worldwide. Neuroleptics are the major class of drugs used in the treatment of schizophrenia. Neuroleptics are associated with wide variety of extrapyramidal side effects such as akathesia, dystonia, neuroleptic malignant syndrome, Parkinsonism and tardive dyskinesia. tardive dyskinesia is a complex hyperkinetic sy...

Oxidative stress and tardive dyskinesia: role of natural antioxidants

Schizophrenia is a devastating psychiatric disorder that affects 1% of population worldwide. Neuroleptics are the major class of drugs used in the treatment of schizophrenia. Neuroleptics are associated with wide variety of extrapyramidal side effects such as akathesia, dystonia, neuroleptic malignant syndrome, Parkinsonism and tardive dyskinesia. tardive dyskinesia is a complex hyperkinetic sy...

Stroke: Challenges, Progress, and Promise

HPV Testing: Promise and Challenges

most common sexually transmitted infections (STIs), is the primary cause of cervical cancer. HPV infection is a necessary but not sufficient precursor to cervical cancer. While the cumulative lifetime incidence of acquiring HPV is 70 to 80 percent in many countries, the vast majority of women with HPV infection will not develop cancer (see PATH’s fact sheet, Natural History of Cervical Cancer)....